Hastings Cent Rep. 2016 Jul;46(4):2. doi: 10.1002/hast.596.
As described by Lori Gruen in the Perspective column at the back of this issue, federally supported biomedical research conducted on chimpanzees has now come to an end in the United States, although the wind-down has taken longer than expected. The process began with a 2011 Institute of Medicine report that set up several stringent criteria that sharply limited biomedical research. The National Institutes of Health accepted the recommendations and formed a committee to determine how best to implement them. The immediate question raised by this transition was whether the IOM restrictions should be extended in some form to other nonhuman primates-and beyond them to other kinds of animals. In the lead article in this issue, Anne Barnhill, Steven Joffe, and Franklin Miller consider the status of other nonhuman primates.
正如 Lori Gruen 在本期封底的观点专栏中所描述的，在美国，尽管比预期的时间要长，但由联邦政府资助的针对黑猩猩的生物医学研究已经结束。这一过程始于 2011 年医学研究所的一份报告，该报告设定了一些严格的标准，大幅限制了生物医学研究。美国国立卫生研究院接受了这些建议，并成立了一个委员会来确定如何最好地实施这些建议。这一转变引发的直接问题是，IOM 的限制是否应该以某种形式扩展到其他非人类灵长类动物——甚至扩展到其他种类的动物。在本期的主要文章中，Anne Barnhill、Steven Joffe 和 Franklin Miller 考虑了其他非人类灵长类动物的状况。
